Trials / Conditions / Stage IVA Papillary Thyroid Cancer

Stage IVA Papillary Thyroid Cancer

4 registered clinical trials studyying Stage IVA Papillary Thyroid Cancer.

Status	Trial	Sponsor	Phase
Completed	Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer NCT01413113	University of Washington	Phase 1
Completed	Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer NCT00519896	University of Washington	Phase 2
Completed	Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unrespon NCT00085293	National Cancer Institute (NCI)	Phase 2
Completed	Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Can NCT00068497	National Cancer Institute (NCI)	N/A